IRINA LEVY: Open Payments
NPI 1104501444 · HICKSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$542 in 20 payments from 8 companies in 2025. Trend: 2023 $44 · 2024 $539 · 2025 $542
Food & beverage: $542
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $253 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Alkermes, Inc. | 4 | $76 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Corium, LLC | 1 | $11 |
Products named: COBENFY, ABILIFY MAINTENA, ARISTADA, INGREZZA, VRAYLAR, LYBALVI, Auvelity, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
